Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by SanFrancisco99on Aug 26, 2014 12:17pm
229 Views
Post# 22878675

RE:RE:How Is Dart Playing This Bet

RE:RE:How Is Dart Playing This Bet

Hi Priceless:  

I did not send those questions.  I decided to wait on it, as I think there are more questions we will want answered and I wanted to think about them for a while.  Then I went on vacation to S. America. I'm back in the USA tomorrow night, although I'm not home yet then.

One additional question I have is this:  I would like to ask them whether or not they ever got an answer to the question of why RVX-208 apparently works with Crestor and not with Lipitor.  My understranding was that they were looking into that question.  By now they might have that information.  IF they do, then it seems to me that it could be (if positive and clear) a very valuable piece of info. It would (could really) provide the "missing link" between a trial failure and a very valuable formula.  If compelling, the information could fix a lot that was previously broken by ASSURE.  It won't re-do the trial of course.

So this question should be added to the list.

I think someone else might have sent that list to Patrick recently.... without my additional question of course.



 

Bullboard Posts